19 results
Running out of Analgesia and Sedation Medications due to #COVID19?  Anand Swaminathan, MD has put
Analgesia and Sedation Medications ... due to #COVID19 ... #management #covid19 ... #treatment #sarscov2 ... #coronavirus #medications
Recent studies have revealed many attractive therapeutic options, even if some of them remain to be
clinical trials #covid19 ... #sarscov2 #management ... #treatment #coronavirus ... #medications
Paxlovid Drug-Drug Interactions
Before prescribing ritonavir-boosted nirmatrelvir (Paxlovid) for outpatient treatment of COVID-19, determine whether the patient
for outpatient treatment ... of COVID-19, determine ... receiving any of the medications ... #pharmacology #COVID19 ... #SARSCOV2 #COVID
Summary of Pharmacology for Select Proposed COVID-19 Treatments

#Pharmacology #Dosing #Table #COVID19 #Coronavirus #SARSCOV2 #Medications #JAMA
Select Proposed COVID ... -19 Treatments ... Dosing #Table #COVID19 ... #Coronavirus #SARSCOV2 ... #Medications #JAMA
Approach to Thrombocytosis - Elevated Platelet Count - Differential Diagnosis Algorithm

Peripheral Smear concerning for malignancy?
→ Refer to hematology ... Rebound effect from treatment ... Inflammatory Conditions: Rheumatologic ... Kawasaki, Nephrotic syndrome ... • Reaction to Medications
Summary of Infections in which Steroids play a role in treatment
 • TB meningitis
 • TB
play a role in treatment ... pneumonia • COVID ... reconstitution inflammatory syndrome ... • Ramsay Hunt syndrome ... #Steroids #Indications
Leukostasis vs Tumor Lysis Syndrome
Leukostasis:
 • Pathophysiology: Large, immature blasts and high WBC count cause hyperviscosity
Leukostasis: • Pathophysiology ... organ damage • Treatment ... : • Pathophysiology ... Low calcium • Treatment ... diagnosis #management #hematology
CNS Manifestations of Systemic Lupus Erythematosus (SLE)

Clinical Manifestations: Demyelinating Syndrome, Headache, Movement disorders, Seizure disorders, Aseptic
Demyelinating Syndrome ... Disease, PRES Pathophysiology ... Puncture, EEG Treatment ... CNS #neurology #rheumatology ... diagnosis #management #treatment
Guillain-Barre Syndrome - Summary

Acute AIDP that presents with rapidly progressive flaccid weakness

Epidemiology:
 • 1-2 cases/100,000 per
Guillain-Barre Syndrome ... Guillain-Barre Pathophysiology ... like illnesses, COVID ... Treatment: • Plasmapheresis ... diagnosis #management #treatment
Differentiation Syndrome in APML
Epidemiology:
 • Incidence: common in APL (2-48% depending on the study)
 • Triggers:
Differentiation Syndrome ... Triggers: ATRA treatment ... Pathophysiology ... Renal Failure Treatment ... Differentiation #Syndrome